From: Gene expression prediction using low-rank matrix completion
Study | Dataset | True positive rate | False positive rate | Precision | Recall | F-measure | AUROC |
---|---|---|---|---|---|---|---|
Lung adenocarcinoma | Original | 0.944 | 0.057 | 0.944 | 0.944 | 0.944 | 0.988 |
 | Low-rank prediction | 0.944 | 0.057 | 0.944 | 0.944 | 0.944 | 0.996 |
 | (O = 60 %) |  |  |  |  |  |  |
 | Sampled Uniform distribution | 0.757 | 0.256 | 0.758 | 0.757 | 0.755 | 0.777 |
 | (O = 60 %) |  |  |  |  |  |  |
Myelodysplastic syndrome | Original | 0.865 | 0.866 | 0.844 | 0.865 | 0.854 | 0.673 |
 | Low-rank prediction | 0.865 | 0.92 | 0.833 | 0.865 | 0.849 | 0.675 |
 | (O = 40 %) |  |  |  |  |  |  |
 | Sampled Uniform distribution | 0.85 | 0.868 | 0.842 | 0.85 | 0.846 | 0.425 |
 | (O = 40 %) |  |  |  |  |  |  |
Pulmonary hypertension | Original | 0.638 | 0.121 | 0.633 | 0.638 | 0.635 | 0.854 |
 | Low-rank prediction | 0.681 | 0.118 | 0.645 | 0.681 | 0.659 | 0.897 |
 | (O = 60 %) |  |  |  |  |  |  |
 | Sampled Uniform distribution | 0.267 | 0.372 | 0.213 | 0.267 | 0.218 | 0.424 |
 | (O = 60 %) |  |  |  |  |  |  |
Pancreatic ductal | Original | 0.782 | 0.218 | 0.784 | 0.782 | 0.782 | 0.886 |
adenocarcinoma | Low-rank prediction | 0.821 | 0.179 | 0.821 | 0.821 | 0.82 | 0.905 |
 | (O = 50 %) |  |  |  |  |  |  |
 | Sampled Uniform distribution | 0.397 | 0.603 | 0.389 | 0.397 | 0.385 | 0.417 |
 | (O = 50 %) |  |  |  |  |  |  |
Psoriasis | Original | 0.912 | 0.088 | 0.913 | 0.912 | 0.912 | 0.96 |
 | Low-rank prediction | 0.912 | 0.088 | 0.912 | 0.912 | 0.912 | 0.956 |
 | (O = 40 %) |  |  |  |  |  |  |
 | Sampled Uniform distribution | 0.641 | 0.359 | 0.641 | 0.641 | 0.641 | 0.648 |
 | (O = 40 %) |  |  |  |  |  |  |